p19 INK4D Antibodies

Santa Cruz Biotechnology features a diverse variety of p19 INK4D monoclonal antibodies for research in cell cycle regulation and tumor biology. p19 INK4D monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). p19 INK4D is a member of the INK4 family of cyclin-dependent kinase inhibitors, playing a crucial role in regulating the cell cycle by inhibiting cyclin D-dependent kinases. p19 INK4D maintains cellular homeostasis and has been implicated in various cancers, making it a significant target for therapeutic research. Understanding p19 INK4D function can provide insights into tumor progression and potential treatment strategies. Researchers can utilize p19 INK4D monoclonal antibodies to explore cell cycle checkpoints and their impact on cancer development. p19 INK4D monoclonal antibodies enable detailed investigation of protein expression patterns and interactions in different cellular environments. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of cell cycle regulation and cancer biology.